Trade ARWR stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Arrowhead Pharmaceuticals, Inc. (ARWR) is trading at US$56.98, down 2.60% today as of Oct 16, 12:21 EDT. The company has a market capitalisation of US$12.3B. Over the past 52 weeks, ARWR has traded between US$36.57 and US$95.49. On Syfe you can trade ARWR with $0 commission and add it to your watchlist.
| Previous close | US$58.50 |
|---|---|
| Market cap | US$12.3B |
| 52-week range | US$36.57 – US$95.49 |
| Volume | 2.01M |
| Exchange | US |
Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
Year: 1995
Arrowhead Pharmaceuticals, Inc. (ARWR) stock is trading at US$56.98, -2.60% from the previous close of US$58.50.
The market cap for Arrowhead Pharmaceuticals, Inc. (ARWR) stock is approximately US$12.3B.
The 52-week high for Arrowhead Pharmaceuticals, Inc. (ARWR) stock is US$95.49.
The 52-week low for Arrowhead Pharmaceuticals, Inc. (ARWR) stock is US$36.57.
Arrowhead Pharmaceuticals, Inc. (ARWR) does not currently pay a dividend.
Stay on top of ARWR
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
